BNGO
Price
$0.20
Change
-$0.00 (-0.00%)
Updated
Dec 20, 04:59 PM (EDT)
CRL
Price
$185.77
Change
+$3.62 (+1.99%)
Updated
Dec 20, 04:59 PM (EDT)
52 days until earnings call
Ad is loading...

BNGO vs CRL

Header iconBNGO vs CRL Comparison
Open Charts BNGO vs CRLBanner chart's image
Bionano Genomics
Price$0.20
Change-$0.00 (-0.00%)
Volume$1.43K
CapitalizationN/A
Charles River Laboratories International
Price$185.77
Change+$3.62 (+1.99%)
Volume$5.04K
CapitalizationN/A
BNGO vs CRL Comparison Chart
Loading...
BNGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNGO vs. CRL commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNGO is a Hold and CRL is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (BNGO: $0.19 vs. CRL: $185.77)
Brand notoriety: BNGO and CRL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BNGO: 77% vs. CRL: 159%
Market capitalization -- BNGO: $57.43M vs. CRL: $13.96B
BNGO [@Medical Specialties] is valued at $57.43M. CRL’s [@Medical Specialties] market capitalization is $13.96B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNGO’s FA Score shows that 1 FA rating(s) are green whileCRL’s FA Score has 0 green FA rating(s).

  • BNGO’s FA Score: 1 green, 4 red.
  • CRL’s FA Score: 0 green, 5 red.
According to our system of comparison, BNGO is a better buy in the long-term than CRL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNGO’s TA Score shows that 4 TA indicator(s) are bullish while CRL’s TA Score has 3 bullish TA indicator(s).

  • BNGO’s TA Score: 4 bullish, 4 bearish.
  • CRL’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BNGO is a better buy in the short-term than CRL.

Price Growth

BNGO (@Medical Specialties) experienced а -18.72% price change this week, while CRL (@Medical Specialties) price change was -2.46% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

BNGO is expected to report earnings on Nov 09, 2023.

CRL is expected to report earnings on Feb 12, 2025.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRL($14B) has a higher market cap than BNGO($57.4M). CRL YTD gains are higher at: -21.417 vs. BNGO (-89.683). CRL has higher annual earnings (EBITDA): 1.03B vs. BNGO (-213.4M). CRL has more cash in the bank: 277M vs. BNGO (102M). BNGO has less debt than CRL: BNGO (79.4M) vs CRL (3.07B). CRL has higher revenues than BNGO: CRL (4.13B) vs BNGO (36.1M).
BNGOCRLBNGO / CRL
Capitalization57.4M14B0%
EBITDA-213.4M1.03B-21%
Gain YTD-89.683-21.417419%
P/E RatioN/A29.15-
Revenue36.1M4.13B1%
Total Cash102M277M37%
Total Debt79.4M3.07B3%
FUNDAMENTALS RATINGS
BNGO vs CRL: Fundamental Ratings
BNGO
CRL
OUTLOOK RATING
1..100
5575
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
77
Overvalued
PROFIT vs RISK RATING
1..100
10082
SMR RATING
1..100
9863
PRICE GROWTH RATING
1..100
9461
P/E GROWTH RATING
1..100
9159
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BNGO's Valuation (27) in the Biotechnology industry is somewhat better than the same rating for CRL (77) in the Miscellaneous Commercial Services industry. This means that BNGO’s stock grew somewhat faster than CRL’s over the last 12 months.

CRL's Profit vs Risk Rating (82) in the Miscellaneous Commercial Services industry is in the same range as BNGO (100) in the Biotechnology industry. This means that CRL’s stock grew similarly to BNGO’s over the last 12 months.

CRL's SMR Rating (63) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for BNGO (98) in the Biotechnology industry. This means that CRL’s stock grew somewhat faster than BNGO’s over the last 12 months.

CRL's Price Growth Rating (61) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for BNGO (94) in the Biotechnology industry. This means that CRL’s stock grew somewhat faster than BNGO’s over the last 12 months.

CRL's P/E Growth Rating (59) in the Miscellaneous Commercial Services industry is in the same range as BNGO (91) in the Biotechnology industry. This means that CRL’s stock grew similarly to BNGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BNGOCRL
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
63%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
70%
Advances
ODDS (%)
Bullish Trend 28 days ago
79%
Bullish Trend 14 days ago
72%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 4 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
77%
View a ticker or compare two or three
Ad is loading...
BNGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXPI12.811.21
+10.43%
eXp World Holdings
HIFS258.429.90
+3.98%
Hingham Institution for Savings
NSPR3.000.02
+0.67%
InspireMD
SLB36.83-0.08
-0.22%
Schlumberger Limited
QLYS140.73-1.87
-1.31%
Qualys

BNGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNGO has been loosely correlated with CERS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BNGO jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNGO
1D Price
Change %
BNGO100%
-2.74%
CERS - BNGO
43%
Loosely correlated
N/A
RVTY - BNGO
43%
Loosely correlated
+1.83%
CRL - BNGO
41%
Loosely correlated
+1.99%
WRBY - BNGO
41%
Loosely correlated
+3.79%
ARAY - BNGO
39%
Loosely correlated
+3.35%
More

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been closely correlated with IQV. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRL jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
+1.99%
IQV - CRL
73%
Closely correlated
+3.00%
CTKB - CRL
60%
Loosely correlated
+2.10%
RGEN - CRL
56%
Loosely correlated
-1.42%
MEDP - CRL
56%
Loosely correlated
+0.64%
AZTA - CRL
55%
Loosely correlated
+1.88%
More